Page last updated: 2024-08-26

2,4-bis(n,n'-di(carboxymethyl)aminomethyl)fluorescein and Cytomegalovirus Infections

2,4-bis(n,n'-di(carboxymethyl)aminomethyl)fluorescein has been researched along with Cytomegalovirus Infections in 1 studies

*Cytomegalovirus Infections: Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Banchenko, S; Binting, L; Bracht, T; Bürger, J; Gotthold, C; Graziadei, A; Jan Lebbink, R; Klingen, R; Lauer, S; Le-Trilling, VTK; Leipe, PM; Malyshkina, A; Mielke, T; Paydar, D; Rappsilber, J; Schwefel, D; Sitek, B; Spahn, CM; Trilling, M; Voigt, S1

Other Studies

1 other study(ies) available for 2,4-bis(n,n'-di(carboxymethyl)aminomethyl)fluorescein and Cytomegalovirus Infections

ArticleYear
Structural mechanism of CRL4-instructed STAT2 degradation via a novel cytomegaloviral DCAF receptor.
    The EMBO journal, 2023, 03-01, Volume: 42, Issue:5

    Topics: Animals; Cryoelectron Microscopy; Cytomegalovirus Infections; Humans; Interferon-Stimulated Gene Factor 3, gamma Subunit; Interferons; Mice; Muromegalovirus; Rats; Receptors, Interleukin-17; STAT2 Transcription Factor; Ubiquitin-Protein Ligases

2023